Discovery of chemerin as the new chemoattractant of human mesenchymal stem cells

BACKGROUND: The homing capacity of human mesenchymal stem cells (hMSCs) to the injured sites enables systemic administration of hMSCs in clinical practice. In reality, only a small proportion of MSCs are detected in the target tissue, which is a major bottleneck for MSC-based therapies. We still don...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Irene, Park, Hyomin, Hwang, Injoo, Moon, Dodam, Yun, Hyunji, Lee, Eun Ju, Kim, Hyo-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252297/
https://www.ncbi.nlm.nih.gov/pubmed/34210352
http://dx.doi.org/10.1186/s13578-021-00631-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252297/
https://www.ncbi.nlm.nih.gov/pubmed/34210352
http://dx.doi.org/10.1186/s13578-021-00631-3

Ejemplares similares